Evidence map›Paper›PMID 37654490›Full record

ArticleFrontiers in immunology2023

Upregulated CD8

Xiaowen Dou, Mian Peng, Ruiwei Jiang, Weiqin Li, Xiuming Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xiaowen DouMedical Laboratory of the Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Mian PengDepartment of Critical Care Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Ruiwei JiangMedical Laboratory of the Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Weiqin LiDepartment of Critical Care Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Xiuming ZhangMedical Laboratory of the Third Affiliated Hospital of Shenzhen University, Shenzhen, China.
Shenzhen Third People’s Hospital · CNShenzhen University · CNNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The primary strategy for reducing the incidence of COVID-19 is SARS-CoV-2 vaccination. Few studies have explored T cell subset differentiation and gene expressions induced by SARS-CoV-2 vaccines. Our study aimed to analyze T cell dynamics and transcriptome gene expression after inoculation with an inactivated SARS-CoV-2 vaccine by using single-cell sequencing. Methods: Single-cell sequencing was performed after peripheral blood mononuclear cells were extracted from three participants at four time points during the inactivated SARS-CoV-2 vaccination process. After library preparation, raw read data analysis, quality control, dimension reduction and clustering, single-cell T cell receptor (TCR) sequencing, TCR V(D)J sequencing, cell differentiation trajectory inference, differentially expressed genes, and pathway enrichment were analyzed to explore the characteristics and mechanisms of postvaccination immunodynamics. Results: Inactivated SARS-CoV-2 vaccination promoted T cell proliferation, TCR clone amplification, and TCR diversity. The proliferation and differentiation of CD8 Conclusion: Upregulation of CD8

Indexed as

COVID-19COVID-19 VaccinesCD8-Positive T-LymphocytesCell DifferentiationGene ExpressionHumansLeukocytes, MononuclearNK Cell Lectin-Like Receptor Subfamily DSARS-CoV-2COVID-19 VaccinesKLRD1 protein, humanNK Cell Lectin-Like Receptor Subfamily DCD8+ MAIT cell differentiationCOVID-19inactivated SARS-CoV-2 vaccineKLRD1 genesingle-cell sequencing

Identifiers

PMID37654490
PMCPMC10466403
OpenAlexW4385954151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.